Publikationen

Houben, RMGJ, Lalli, M, Kranzer, K, Menzies, NA, Schumacher, SG & Dowdy, DW 2019, 'What if they don't have tuberculosis? The consequences and trade-offs involved in false-positive diagnoses of tuberculosis' CLINICAL INFECTIOUS DISEASES, Jg. 68, Nr. 1, S. 150-156. https://doi.org/10.1093/cid/ciy544

Khalil, ZG, Hill, TA, De Leon Rodriguez, LM, Lohman, R-J, Hoang, HN, Reiling, N, Hillemann, D, Brimble, M, Fairlie, D, Blumenthal, A & Capon, RJ 2019, 'Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis' ANTIMICROBIAL AGENTS AND CHEMOTHERAPY.

Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. PubMed PMID: 31315696.

Rybniker, J, Andreas Kohl, T, Barilar, I & Niemann, S 2019, 'No evidence for acquired mutations associated with cytochrome bc1-inhibitor resistance in 13,559 clinical Mycobacterium tuberculosis complex isolates' ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jg. 63, Nr. 1. https://doi.org/10.1128/AAC.01317-18

von Bargen, K, Scraba, M, Krämer, I, Ketterer, M, Nehls, C, Krokowski, S, Repnik, U, Wittlich, M, Maaser, A, Zapka, P, Bunge, M, Schlesinger, M, Huth, G, Klees, A, Hansen, P, Jeschke, A, Bendas, G, Utermöhlen, O, Griffiths, G, Gutsmann, T, Wohlmann, J & Haas, A 2019, 'Virulence-associated protein A from Rhodococcus equi is an intercompartmental pH-neutralising virulence factor' CELLULAR MICROBIOLOGY, Jg. 21, Nr. 1, S. e12958. https://doi.org/10.1111/cmi.12958